Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) announced a globa agreement to develop and commercialize fasinumab, Regeneron’s investigational NGF antibody in …
Analyst Chris Schott of J.P.
Following Teva’s guidance revision, Piper Jaffray analyst David Amsellem maintained a Neutral rating on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and lowered his …
The drama between Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan NV (NASDAQ:MYL) continues, this time around in the courts instead of the …
Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) announced the presentation of further data from its chronic migraine phase 2b study evaluating the efficacy and safety, versus …
